Repligen Announces Long Term Supply Agreement with GE Healthcare for Recombinant Protein A

Repligen Corporation announced today that it has extended its longstanding relationship with GE Healthcare Bio-Sciences AB by entering into a five-year supply agreement for recombinant Protein A, a consumable used in the manufacture of monoclonal antibodies, a highly successful class of biopharmaceutical.  Repligen is the world’s leading supplier of recombinant Protein A and has manufactured [...]